Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00147693|
Recruitment Status : Completed
First Posted : September 7, 2005
Last Update Posted : October 1, 2008
The objective is to ascertain the potential efficiency of a systematic care programme for caregivers of dementia patients. The research questions are:
- What are the costs and benefits of the Systematic Care Programme - Dementia (SCP-Dementia), as compared with usual care?
- What are the effects on the quality of life of patients and informal caregivers (spouse, relative), as compared with usual care?
|Condition or disease||Intervention/treatment|
|Dementia, Vascular Dementia Alzheimer Disease Lewy Body Disease||Behavioral: Diagnosis of caregivers' problems Behavioral: Professional service: treatment of problems by counseling or practical support|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||304 participants|
|Intervention Model:||Factorial Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||Systematic Care for Informal Caregivers of Dementia Patients: An Efficient Approach?|
|Study Start Date :||June 2005|
|Primary Completion Date :||February 2006|
|Study Completion Date :||February 2006|
- Patients admissions to nursing homes or residential homes. This outcome is the most important input for the estimation of cost differences between the intervention group and controls. [ Time Frame: after one year follow-up period ]
- Secondary outcome for cost estimation is patient and caregiver related costs estimated by "Resource Utilisation in Dementia" (RUD), including time spent on caregiving, use of health care services by caregivers and patients and additional productivity.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00147693
|Radboud University Nijmegen Medical Centre|
|Principal Investigator:||Myrra M Vernooij-Dassen, PhD||Coordinator Alzheimer Centre UMC Nijmegen|